Wan Sun

588 total citations
24 papers, 322 citations indexed

About

Wan Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Wan Sun has authored 24 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Wan Sun's work include Advanced Breast Cancer Therapies (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). Wan Sun is often cited by papers focused on Advanced Breast Cancer Therapies (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). Wan Sun collaborates with scholars based in United States, China and United Kingdom. Wan Sun's co-authors include Diane Wang, Richard S. Finn, Anna Plotka, Melissa O’Gorman, Sylvester Pawlak, Karen J. Klamerus, Maha Kosa, Nicholas C. Turner, Geoffrey I. Shapiro and Angela DeMichele and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Wan Sun

23 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wan Sun United States	10	149	145	71	51	39	24	322
Ryan Geschwindt United States	10	80 0.5×	137 0.9×	17 0.2×	94 1.8×	37 0.9×	15	337
Chien‐Hsing Lin Taiwan	10	89 0.6×	69 0.5×	30 0.4×	116 2.3×	96 2.5×	21	366
Martin J. Bury United States	10	202 1.4×	65 0.4×	13 0.2×	55 1.1×	37 0.9×	23	314
Jessica Boklan United States	12	118 0.8×	55 0.4×	62 0.9×	215 4.2×	41 1.1×	30	467
Mindy K. Graham United States	11	98 0.7×	59 0.4×	27 0.4×	203 4.0×	54 1.4×	18	352
Nick B. Tsavaris Greece	6	204 1.4×	68 0.5×	47 0.7×	69 1.4×	19 0.5×	9	410
Rami Darwich Canada	10	127 0.9×	35 0.2×	14 0.2×	101 2.0×	15 0.4×	18	334
Yi-Cheng Wang United States	12	90 0.6×	30 0.2×	55 0.8×	276 5.4×	53 1.4×	15	517
J. Casal Spain	10	195 1.3×	170 1.2×	9 0.1×	40 0.8×	43 1.1×	29	327
R. C. Horns United States	6	176 1.2×	57 0.4×	24 0.3×	159 3.1×	65 1.7×	11	411

Countries citing papers authored by Wan Sun

Since Specialization

Citations

This map shows the geographic impact of Wan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Sun more than expected).

Fields of papers citing papers by Wan Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Sun. The network helps show where Wan Sun may publish in the future.

Co-authorship network of co-authors of Wan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Wan Sun. A scholar is included among the top collaborators of Wan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan Sun. Wan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mei, Zhanlong, et al.. (2025). SMQVP: A Web Application for Spatial Metabolomics Quality Visualization and Processing. Metabolites. 15(6). 354–354. 2 indexed citations

Wang, Zhanjun, Jie Li, Xuyuan Liu, et al.. (2024). Transcriptomic analysis of codon usage patterns and gene expression characteristics in leafy spurge. BMC Plant Biology. 24(1). 1118–1118. 2 indexed citations

Zhu, Lei, Xingxing Jian, Melba Muñoz, et al.. (2024). Gut microbiota facilitate chronic spontaneous urticaria. Nature Communications. 15(1). 112–112. 32 indexed citations

Xu, Binghe, Huiping Li, Qingyuan Zhang, et al.. (2021). Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women. Cancer Chemotherapy and Pharmacology. 88(1). 131–141. 11 indexed citations

Sun, Wan, Blair Fennimore, Dawn B. Beaulieu, et al.. (2021). Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease. Clinical Pharmacokinetics. 60(6). 811–818. 9 indexed citations

Wang, Xueqing, et al.. (2021). Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil/lymphocyte ratio of stage IB2-IIB cervical cancer.. PubMed. 25(2). 757–763. 12 indexed citations

Yu, Yanke, Wan Sun, Yuan Liu, & Diane Wang. (2021). Pharmacodynamic Modeling of CDK4/6 Inhibition‐Related Biomarkers and the Characterization of the Relationship Between Biomarker Response and Progression‐Free Survival in Patients With Advanced Breast Cancer. The Journal of Clinical Pharmacology. 62(3). 376–384. 2 indexed citations

Hou, Gege, Sujun Liu, Wan Sun, et al.. (2020). Identification of microRNAs in developing wheat grain that are potentially involved in regulating grain characteristics and the response to nitrogen levels. BMC Plant Biology. 20(1). 87–87. 36 indexed citations

Sun, Wan, Richard A. Lirio, Jennifer M. Schneider, et al.. (2020). Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases. Clinical Pharmacology in Drug Development. 10(7). 734–747. 7 indexed citations

10.

Sun, Wan, Blair Fennimore, Dawn B. Beaulieu, et al.. (2020). P509 Vedolizumab levels in breast milk: Results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease. Journal of Crohn s and Colitis. 14(Supplement_1). S442–S442. 1 indexed citations

11.

Sun, Wan, Di Zhou, John Harley Warner, et al.. (2020). Huntington's Disease Progression: A Population Modeling Approach to Characterization Using Clinical Rating Scales. The Journal of Clinical Pharmacology. 60(8). 1051–1060. 9 indexed citations

12.

Rosario, Maria, et al.. (2019). P490 A vedolizumab population pharmacokinetic model including intravenous and subcutaneous formulations for patients with ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S357–S357. 9 indexed citations

13.

Rosario, Maria, Nathanael L. Dirks, R J Lock, et al.. (2019). P529 Exposure–response relationship of vedolizumab subcutaneous treatment in patients with ulcerative colitis: VISIBLE 1. Journal of Crohn s and Colitis. 13(Supplement_1). S377–S378. 4 indexed citations

14.

Rugo, Hope S., Nicholas C. Turner, Richard S. Finn, et al.. (2018). Palbociclib plus endocrine therapy in older women with HR+/HER2– advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies. European Journal of Cancer. 101. 123–133. 59 indexed citations

15.

Li, Huiping, Qingyuan Zhang, Shusen Wang, et al.. (2017). Palbociclib plus letrozole as first-line treatment for ER-positive and HER2-negative advanced breast cancer in Chinese women: a phase 1 study. The Lancet Oncology. 18. S7–S7. 4 indexed citations

16.

Rugo, HS, Nicholas C. Turner, RS Finn, et al.. (2017). Abstract P4-22-03: Palbociclib in combination with endocrine therapy in treatment-naive and previously treated elderly women with HR+, HER2– advanced breast cancer: a pooled analysis from randomized phase 2 and 3 studies. Cancer Research. 77(4_Supplement). P4–22. 5 indexed citations

17.

Sun, Wan, et al.. (2017). Palbociclib exposure-response analyses in second-line treatment of hormone-receptor positive advanced breast cancer (ABC).. Journal of Clinical Oncology. 35(15_suppl). 1053–1053. 8 indexed citations

18.

Wang, Diane D., Chunze Li, Wan Sun, et al.. (2014). PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues – A population pharmacokinetic/pharmacodynamic analysis of rucaparib. Clinical Pharmacology in Drug Development. 4(2). 89–98. 3 indexed citations

19.

Sun, Wan, Thomas Laughren, Hao‐Jie Zhu, Günther Hochhaus, & Yaning Wang. (2013). Development of a placebo effect model combined with a dropout model for bipolar disorder. Journal of Pharmacokinetics and Pharmacodynamics. 40(3). 359–368. 11 indexed citations

20.

Qin, Shuang, et al.. (2011). [Clinical and laboratory investigation of patients with hematologic malignancies harboring der(1;7)(q10;p10)].. PubMed. 28(4). 441–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact